MAI Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Buy
2,021
+369
+22% +$207K ﹤0.01% 941
2026
Q1
$928K Buy
1,652
+84
+5% +$53.9K 0.01% 804
2025
Q4
$1.06M Buy
1,568
+37
+2% +$25.2K 0.01% 720
2025
Q3
$978K Buy
1,531
+466
+44% +$283K 0.01% 717
2025
Q2
$571K Buy
1,065
+196
+23% +$93.7K ﹤0.01% 810
2025
Q1
$365K Buy
869
+7
+0.8% +$3.04K ﹤0.01% 911
2024
Q4
$356K Buy
862
+289
+50% +$127K ﹤0.01% 943
2024
Q3
$289K Sell
573
-340
-37% -$165K ﹤0.01% 893
2024
Q2
$445K Buy
913
+18
+2% +$9.04K ﹤0.01% 850
2024
Q1
$483K Buy
895
+38
+4% +$20.8K 0.01% 810
2023
Q4
$476K Buy
857
+33
+4% +$15.5K 0.01% 719
2023
Q3
$360K Buy
824
+88
+12% +$43.9K 0.01% 746
2023
Q2
$370K Buy
736
+138
+23% +$66.1K 0.01% 745
2023
Q1
$299K Buy
598
+82
+16% +$39.2K ﹤0.01% 805
2022
Q4
$211K Buy
+516
New +$200K ﹤0.01% 896
2016
Q2
Sell
-10,934
Closed -$856K 434
2016
Q1
$856K Buy
10,934
+14
+0.1% +$1.01K 0.07% 193
2015
Q4
$796K Buy
10,920
+140
+1% +$9.99K 0.06% 209
2015
Q3
$800K Sell
10,780
-140
-1% -$10K 0.06% 220
2015
Q2
$700K Sell
10,920
-300
-3% -$20.8K 0.05% 255
2015
Q1
$867K Sell
11,220
-120
-1% -$9.34K 0.06% 226
2014
Q4
$841K Hold
11,340
0.06% 219
2014
Q3
$668K Buy
11,340
+424
+4% +$26.8K 0.06% 213
2014
Q2
$729K Buy
10,916
+1,876
+21% +$119K 0.07% 187
2014
Q1
$549K Sell
9,040
-350
-4% -$20.9K 0.06% 212
2013
Q4
$499K Sell
9,390
-5,808
-38% -$306K 0.05% 223
2013
Q3
$757K Hold
15,198
0.1% 140
2013
Q2
$682K Buy
+15,198
New +$664K 0.09% 142

Other funds holding IDXX

MAI Capital Management's IDXX Position: Q2 2026 in Review

MAI Capital Management increased its Idexx Laboratories (IDXX) stake by 22% in Q2 2026, buying an estimated $207K and bringing the position to 2,021 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #941.

MAI Capital Management first reported a position in IDXX in Q2 2013 and has held it in 27 quarters since. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • MAI Capital Management held 2,021 shares of Idexx Laboratories worth $1.06M as of Q2 2026.
  • MAI Capital Management bought 369 Idexx Laboratories shares in Q2 2026, an estimated $207K.
  • Idexx Laboratories made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #941 holding.
  • MAI Capital Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 27 quarters since.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.